Brief Communication: Better Ways To Question Patients about Adverse Medical Events: A Randomized, Controlled Trial
The DOI matches its Crossref record, with a small difference in title or year; 11 of the 11 references it cites were found in a registry or an index.
Abstract
BACKGROUND: There is no standard method of identifying adverse events in clinical trials. OBJECTIVE: To determine whether 3 different methods of questioning patients about adverse events in a clinical trial affect the frequency of reported events. DESIGN: Randomized, single-blind, controlled trial. SETTING: A Veterans Administration medical center, San Francisco, California. PARTICIPANTS: Men 50 years of age or older who had benign prostatic hyperplasia. MEASUREMENT: Frequency of self-reported medical problems. INTERVENTION: The authors randomly assigned 214 men who were undergoing a 1-month, single-blind, placebo run-in period during an existing clinical trial to 3 groups to test different self-administered methods of assessing medical problems at the end of the run-in period. The first group was asked an open-ended question; the second group was asked an open-ended, defined question; and the third group was given a checklist of 53 common side effects. RESULTS: All 214 patients completed the study. Patients assigned to the checklist group reported a total of 238 adverse events; in comparison, patients who were asked an open-ended question or an open-ended, defined question reported 11 and 14 adverse events, respectively (P < 0.001). The percentage of patients reporting any adverse event was also much higher in the group assigned to the checklist (77%) than in the first group (14%) or second group (13%) (P < 0.001). LIMITATIONS: The study included only relatively healthy, well-educated, middle-aged men and assessed only self-reported medical problems after the participants had taken placebo for 1 month. All personnel overseeing the study were aware of the group assignments. CONCLUSIONS: Different methods of collecting patient data regarding adverse events lead to large differences in the reported rates of adverse events in clinical trials, potentially reducing the validity of comparisons between the side effect profiles of drugs and other interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For instance, although actively prompting meditators to disclose potential particularly unpleasant meditation-related experiences might increase the rate of reporting compared to passive monitoring, medical research indicates that the estimates from active monitoring might be more accurate [49, 50].”
From Unpleasant meditation-related experiences in regular meditators: Prevalence, predictors, and conceptual considerations (2019) · cites this paper as [49]
In the citing paper
“As a result, passive monitoring is thought to underestimate AE prevalence by more than 20-fold [58].”
From The varieties of contemplative experience: A mixed-methods study of meditation-related challenges in Western Buddhists (2017) · cites this paper as [58]
In the citing paper
“In addition, very few MBI trials actively measure adverse effects [58], relying instead on passive monitoring, which can underestimate the actual frequency by more than 20-fold [59,60].”
From Can mindfulness be too much of a good thing? The value of a middle way (2019) · cites this paper as [59]
In the citing paper
“How harms outcomes are assessed will affect the results obtained.276 277 278 279”
From SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials (2025) · cites this paper as [277]
Citations
Cites
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593
Reidenberg, M. M., Lowenthal, D. T., & Sacks, R. (1968) · New England Journal of Medicine · doi:10.1056/nejm196809262791304 · Cited by 242
DESIGN AND REPORTING MODIFICATIONS IN INDUSTRY-SPONSORED COMPARATIVE PSYCHOPHARMACOLOGY TRIALS
SAFER, D. J. (2002) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200209000-00002 · Cited by 180
Extracts from "Clinical Evidence": Non-steroidal anti-inflammatory drugs
Gotzsche, P. C. (2000) · BMJ · doi:10.1136/bmj.320.7241.1058 · Cited by 127
Ethgen, M., Boutron, I., Baron, G., Giraudeau, B., Sibilia, J., & Ravaud, P. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-1-200507050-00006 · Cited by 49 · cited 3×
“7) Ethnicity, n (%) White 173 (81) 53 (77) 59 (84) 61 (83) Black 12 (6) 5 (7) 3 (4) 4 (5) Asian 14 (6) 6 (9) 4 (6) 4 (5) Hispanic 11 (5) 3 (4) 3 (4) 5 (7) Other 4 (2) 2 (3) 1 (2) 0 (0) Completed college, n (%) 145 (68) 43 (61) 52 (74) 50 (68) Mean score on the American Urological Association Symptom Index (SD)* 15.”
BackgroundEvaluation of three methods of symptom reporting in a clinical trial of felodipine
Wallander, M.-A. A., Dimen�s, E. S., Sv�rdsudd, K., & Wiklund, I. E. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315428 · Cited by 27
Detection of adverse drug reactions in a clinical trial using two types of questioning.
Wallin, J. E., & Sjövall, J. (1981) · PubMed · Cited by 23
Side Reactions in Neurotics: I. A Comparison of Two Methods of Assessment
Downing, R. W., Rickels, K., & Meyers, M. F. (1970) · The Journal of Clinical Pharmacology · doi:10.1177/009127007001000501 · Cited by 22
Greenblatt, M. (1964) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196456part2864 · Cited by 14
Research works printed but not linked: 1
- Wallin J, 1981, Clin Ther, 3, 450
Cited by
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
Van Dam, N. T., van Vugt, M. K., Vago, D. R., Schmalzl, L., Saron, C. D., Olendzki, A., Meissner, T., Lazar, S. W., Kerr, C. E., Gorchov, J., et al. (2018) · Perspectives on Psychological Science · doi:10.1177/1745691617709589 · Cited by 1,506
Newman, C. B., Preiss, D., Tobert, J. A., Jacobson, T. A., Page, R. L., Goldstein, L. B., Chin, C., Tannock, L. R., Miller, M., Raghuveer, G., et al. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atv.0000000000000073 · Cited by 738
Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70910-x · Cited by 653
Metadata
- Authors
- Bent, S., Padula, A., & Avins, A. L.
- Affiliations
- San Francisco VA Medical Center (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2006-02-21
- Volume
- 144
- Issue
- 4
- Pages
- 257-261
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2020924652
- Cited by
- 177
- References
- 11
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 2 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 10 · 2019: 10 · 2018: 7 · 2017: 10 · 2016: 13 · 2015: 9 · 2014: 8 · 2013: 12 · 2012: 4
- FWCI
- 19.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Annals of Internal Medicine
- Funders
- U.S. Public Health Service (1 K08 ATO1338-01)
- National Institute of Diabetes and Digestive and Kidney Diseases (1 R01 DK56199-01, R01DK056199)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Sociology and Political Science › Survey Methodology and Nonresponse
- Keywords
- adverse event reporting, self-administered questionnaire, open-ended questions, side effect profile, drug safety, benign prostatic hyperplasia, patient-reported outcomes
- MeSH terms
- Aged, Humans, Male, Middle Aged, Surveys and Questionnaires, Randomized Controlled Trials as Topic, Single-Blind Method, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Brief Communication: Better Ways To Question Patients about Adverse Medical Events: A Randomized, Controlled Trial. https://app.cochat.ai/papers/10.7326/0003-4819-144-4-200602210-00007
- The paper
- Bent, S., Padula, A., & Avins, A. L. (2006). Brief Communication: Better Ways To Question Patients about Adverse Medical Events: A Randomized, Controlled Trial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-144-4-200602210-00007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.